Multiple Sclerosis Secondary Progressive Form clinical trials

Explore recruiting multiple sclerosis secondary progressive form clinical trials.

Also recruiting in Europe

Multiple Sclerosis Secondary Progressive Form trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CLASP MS: The study evaluating the efficacy and safety of Polish cladribine in the treatment of patients with secondary progressive multiple sclerosis - a phase 2, randomized, double-blind, placebo-controlled trial.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Multiple Sclerosis Secondary Progressive Form trials by city

Multiple Sclerosis Secondary Progressive Form in Toronto Multiple Sclerosis Secondary Progressive Form in Vancouver Multiple Sclerosis Secondary Progressive Form in Montreal Multiple Sclerosis Secondary Progressive Form in Calgary Multiple Sclerosis Secondary Progressive Form in Edmonton Multiple Sclerosis Secondary Progressive Form in Ottawa Multiple Sclerosis Secondary Progressive Form in Winnipeg Multiple Sclerosis Secondary Progressive Form in Quebec City Multiple Sclerosis Secondary Progressive Form in Hamilton Multiple Sclerosis Secondary Progressive Form in Kitchener Multiple Sclerosis Secondary Progressive Form in London Multiple Sclerosis Secondary Progressive Form in Halifax Multiple Sclerosis Secondary Progressive Form in New York Multiple Sclerosis Secondary Progressive Form in Los Angeles Multiple Sclerosis Secondary Progressive Form in Chicago Multiple Sclerosis Secondary Progressive Form in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease